This presentation was delivered to the DDN Conference in 2016, the conference topic was “Get the picture” and they had asked me to present on using photography. This doesn’t contain any drug information or advice on harm reduction, it does however have basic photography advice and some good portraits from the harm reduction movement.

This presentation was delivered to the Harm Reduction Coalition conference in Baltimore, it’s designed as a primer into the kinds of argument normally used against harm reduction.

This presentation was delivered to the National Needle Exchange Forum event. It covers some of the things to keep in mind to make sure naloxone is a core intervention in drug services since the Oct 2015 law changes.

This presentation on the importance of families being involved with naloxone advocacy was delivered to the ADFAM Families First conference in 2013.

This presentation was delivered to the National Needle Exchange Forum meeting in Bournemouth. I was talking about the Harm Reduction Cafe community project that I’ve developed as part of my job with HIT.

This presentation on the psychology of injecting rituals and the ways we can use these within our harm reduction approaches was delivered at the HIT Hot Topics conference in Liverpool and at the Harm Reduction Coalition conference. The video was filmed in Liverpool.

This presentation was delivered to the UK Recovery Federation who invited me to speak at their conference on how Harm Reduction and Recovery could work more closely together.

This presentation was delivered to the National Needle Exchange Forum meeting in Bristol. I was asked to talk about the Outcomes Tool for needle programmes that I developed.

This presentation is designed for use alongside the Overdose Workshop, it contains a section of the overdose myths quiz, a video on the recovery position and other tools to make running a workshop go smoothly.

This presentation was delivered to the National Conference on Injecting Drug Use (and later to the Irish Drugs Conference), the focus is why injectors may often ‘choose’ to share even knowing that this is a risk factor for BBVs.